Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-11

Clinical Trial Update: Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating weight-management strategies plus Megestrol acetate for early-stage endometrioid endometrial cancer in obese pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Xiaojun Chen | Conditions: Endometrial Carcinoma, Obese | Phase 2, Phase 3 | Status: RECRUITING